chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I tested positive on June 1st; I tested positive on June 1st; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number and Expiration date was not reported), via an unspecified route of administration on 28Apr2021 as 2nd dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Previously patient took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 07Apr2021 for COVID-19 immunization. It was reported that patient got the Pfizer Vaccine on 07Apr2021, second shot on 28Apr2021. Patients wife and patient visited another country. Patients wife has the Johnson & Johnson vaccine. Patients wife tested positive for COVID-19 on 26May2021. Patient tested positive on 01Jun2021 and Patients wife's aunt, who had one shot of Sinovac, tested positive a few days later. That's three vaccinated people spreading it to each other. Patient wanted to make aware of this, as the vaccines seem to be ineffective at preventing infection by whatever strain we got. The outcome of the events was unknown.  Information about batch/Lot number has been requested.
(10 prior). Parent gave dose of Children's Tylenol prior to vaccination. One hour after DTaP complained of "stiffness" whole body, dizzy, tired, lack of appetite, rapid heart rate and fever. Fever was highest at 103 deg. Tylenol given every 4 hrs. Vomit x1 during night. Today, fever is down, talking, seems "O.K." No swelling and redness where shot given. Referred to PMD for evaluation.
Erythema at vaccine site. DTaP #4 on 11/14/14 at 10:30 AM. Rash maculopapular started on 11/14/14 at around 8:00 PM. Rash covers neck to feet including palms of hands/feet.
no wonder your vaccine almost killed me; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (no wonder your vaccine almost killed me) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (no wonder your vaccine almost killed me). At the time of the report, IMMUNISATION REACTION (no wonder your vaccine almost killed me) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications were provided by the reporter. It was reported that no wonder your vaccine almost killed. No treatment information was provided by the reporter.
Had ruptured blood vessels x 2 spontaneously in eyes; This is a spontaneous report from a contactable nurse reported for herself. A 54-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EK5730), via an unspecified route of administration on 17Dec2020 03:00 P.M at single dose for covid-19 immunization. The facility type vaccine was: workplace clinic. Medical history included manifesting carrier BMD (Becker's muscular dystrophy). Allergies to medication: allergies rash on Sulfa. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included pregabalin (LYRICA), duloxetine hydrochloride (DULOXETINE [DULOXETINE HYDROCHLORIDE]). The patient experienced ruptured blood vessels x 2 spontaneously in eyes (eye haemorrhage) on 18Dec2020 with outcome of recovered. No treatment received. The action taken in response to the event for BNT162B2 was not applicable.; Sender's Comments: Based on the available information, the company considers that a causal relationship between the eye haemorrhage and vaccination with BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
pt recvd vax; feels hot then chills, body aches, HA, apap q 4 hrs;
Bell's Palsy; This case was reported by a physician via call center representative and described the occurrence of bell's palsy in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, 1 day after receiving Shingrix, the patient experienced bell's palsy (serious criteria GSK medically significant). On an unknown date, the outcome of the bell's palsy was unknown.   It was unknown if the reporter considered the bell's palsy to be related to Shingrix.  Additional information was received as follows: On an unknown date, patient was given Shingrix in the office and the following day developed Bell's Palsy. The report was submitted with limited details as provided on web request form.
CDC reports: 2 mo infant developed adenopathy at inject site area & screaming episode for more than 4 hrs following DTP/OPV immunization. Hospitalized 1 day. Child to receive DT only in future.
p/receiving vax pt had a high pitch scream; pt would not eat or sleep; In the evening pt settled down & would eat; pt was fine next day;
Large red welt - about 2 inches in diameter. Hot to the touch, hard. When I researched this online, I realized the intradermal shot is only approved for ages 18-64, so she should not have received it!
Pt seen for health maintenance exam on 8/26/10. Patient had screen CBC, ESR, Rheumatoid factor for screen of joint sxs at visit -> all normal. Pt had hx of clear rhinorrhea without fever for several days before visit -> suspected URI. Exam was unremarkable at health maintenance exam. Patient given PCV-13 vaccine and discharge home. Patient called provider on call on 8/27/10 at 1015 pm with another onset of fever of 104.6 degrees F. Patient had no sign of local irritation, continued with rhinorrhea but had no other sxs (no cough, no rash). Patient continued to have intermittent fever x 36hrs and was ultimately evaluated 8/28/10 at a local urgent care center. Laboratory assessment is as documented on page 1. Assessment was suspected viral upper respiratory tract illness. Pt was discharged home. F/u phone call 8/30/10 - fever resolved, pt doing well. I am very suspicious that the fever was vaccine related.
Fever 101, dizziness, trouble standing, body aches, bones hurt, chills, coughing, lethargy
Severe burning neck pain; Post-Herpetic Neuralgia  like symptoms; This case was reported by a physician via call center representative and described the occurrence of neck pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced neck pain and post herpetic neuralgia. On an unknown date, the outcome of the neck pain and post herpetic neuralgia were unknown.   It was unknown if the reporter considered the neck pain and post herpetic neuralgia to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient developed severe burning neck pain and post herpetic like symptoms after receiving Shingrix.  The reporter consented to follow up. The consult neurologist did not administer the vaccine.
Pt reported (3 months later) that she developed herpes zoster approximately 10 days after receiving Zostavax on 5/22/08.   Pt did not seek medical treatment. Pt was on 15mg prednisone at time of vaccination and had been on 20 mg prednisone for months prior to decreasing dose 5 weeks prior to vaccination.
Left thigh swollen, taught, around entire circumference of thigh 2 1/2" diam and of erythema at injection site over mid-lateral.
I woke up with a fever of over 100. I had a cough, very sore throat, really bad headache and chills during the day. My teeth were also hurting. When I called the nurse, she asked me if I had any chronic conditions or anything. I don't have anything so she said I wouldn't qualify for any oral treatments. I used ibuprofen and TYLENOL at home. I'm still testing positive today.
I received my first Covid 19 Moderna vaccine (lot 001A21A) on 3/5/2021. I received my second Covid 19 Moderna vaccine dose (lot 017B21A) on 4/2/2021. On 4/11/2021, I awoke to excruciating, bilateral pain in my hips and shoulders. I could walk only with difficulty and I had trouble dressing myself. This pain persisted for days and, after testing to rule out Lupus and Rheumatoid Arthritis, I saw rhematologist Dr. at Health Center on 5/5/2021. She diagnoses me as suffering from PolyMyalgia Rheumatica and prescribes MethylPrednisolone 16mg.  Over the course of a few days, the pain subsided and I remain on this dose of MethylPrednisolone today and continue to see Dr. monthly to track the status of my Polymyalgia Rheumatica.  She suggested that I post my experience on VAERS because she has seen some other instances of Polymyalgia Rheumatica proximal to the Covid vaccine.
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 30-Sep-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided. No treatment details were provided. It was reported that Date of refrigeration was given as  08/19/2021.
Right arm red, swollen, has fever, nausea, body aches, no rash or hives.
Extreme shaking; Dizziness/ light headedness; Body hurt; In bed for 48 hours; Migraine; Headache; Chills/ chattering of teeth; Intense body aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Extreme shaking), DIZZINESS (Dizziness/ light headedness), PAIN (Body hurt), MOVEMENT DISORDER (In bed for 48 hours) and MIGRAINE (Migraine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 011AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included HYDROXYCHLOROQUINE, METFORMIN, ASPIRIN [ACETYLSALICYLIC ACID] and DEXLANSOPRAZOLE (DEXILANT) for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced NAUSEA (Nausea). On 11-Apr-2021, the patient experienced TREMOR (Extreme shaking), DIZZINESS (Dizziness/ light headedness), PAIN (Body hurt), MOVEMENT DISORDER (In bed for 48 hours), MIGRAINE (Migraine), HEADACHE (Headache), CHILLS (Chills/ chattering of teeth) and MYALGIA (Intense body aches). At the time of the report, TREMOR (Extreme shaking), DIZZINESS (Dizziness/ light headedness), PAIN (Body hurt), MOVEMENT DISORDER (In bed for 48 hours), MIGRAINE (Migraine), NAUSEA (Nausea), HEADACHE (Headache), CHILLS (Chills/ chattering of teeth) and MYALGIA (Intense body aches) outcome was unknown.            No treatment information was provided.   This case was linked to MOD-2021-076281 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow-up received on 06-MAY-2021 included no new information.
Headache (migraine-like), extreme fatigue, nausea  all lasted for 36 hours
Muscle soreness in left arm and upper shoulder starting evening of injection continuing through 3rd day. Fever/chills, headache starting the next day, 1/24/21  8am through 5am 1/25/21.
Hep A #3 given accidentally on 8/14/08.  Hep A #2 given 3/6/08.
Employee calling to report a reaction after receiving a COVID-19 vaccine.    Vaccine Name -  Pfizer  Vaccine Lot # - EJ1685  Vaccine Date and time  - ? 12/19/2020 @ 2:40pm  Is this your first or second dose? First  Date and time of symptom onset - ?  12/19/2020 @ 10pm  Symptoms - ?  congestion, dry cough, harsh voice  Last day of work and shift - ?  12/20/2020 11:30am-8pm  Home remedies? -    none  Any improvement? -  no  Recommendation?  Referred to Employee Health command center for Covid-19 testing  Employee voiced understanding Employee of information ? yes   Employee voiced any concerns ? yes   Employee?s questions answered to employee?s satisfaction - yes
diarrhea; nausea; low grade fever of 98 or 99; This case was reported by a consumer via call center representative and described the occurrence of diarrhea in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix) and Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season).   On 8th January 2021, the patient received the 2nd dose of Shingrix. On 11th January 2021, 3 days after receiving Shingrix and an unknown time after receiving Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced diarrhea and nausea. In January 2021, the patient experienced fever. On an unknown date, the outcome of the diarrhea, nausea and fever were recovering/resolving.  It was unknown if the reporter considered the diarrhea, nausea and fever to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient for herself. The patient received flu vaccine and Shingrix on November 2020. For tolerance of 1st dose of Shingrix and Flu vaccine , refer case US2021008404. The patient waited two months after 1st dose to get the 2nd shot of Shingrix on 8th January 2021 and on Monday, 11th January 2021 she started to experience diarrhea and nausea.  On Tuesday from the day of reporting it got really bad and today on the day of reporting her symptoms were improving  The Patient also had a low grade fever of 98 or 99 degree Fahrenheit. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021008406:same reporter US-GLAXOSMITHKLINE-US2021008404:same reporter, same product, different dose
This spontaneous report was received from a 21 year old female patient reporting on herself. The patient's concurrent conditions and medical history were not provided. On an unknown date, the patient was vaccinated with the first dose of GARDASIL (lot #, dose, frequency and route were not provided). Concomitant therapies were not provided. On an unknown date, the patient was unavailable to receive her second dose of GARDASIL due to temperature excursion as the patient picked up the vaccine from the pharmacy and was unable to store it properly before the schedule administration date. The incorrectly store vaccine was not administered. No further adverse event information was provided. Additional information has been requested.
pt w/fever 102-104 w/in 2hr of vax;By 8PM pt w/tonic-clonic sz w/hourly occurrence hard to control-sz became more focal w/lt side involvement-on day 4  irritable, thrashing aggressive behavior & recurrent sz;refusing to walk;
Pt denied having a previous Covid vaccination on questionaire.  issues with Language communication barriers.  Nurse gave J&J vaccination & presented card to pt.  He then showed nurse another card saying he had received Moderna on 2/6/21 at a differnet site.  He explained he had received an email to get his 2nd Moderna shot, so he made appointment here instead of original site.    Pt observed for 30 minutes without any adverse reactions.
Information has been received from a nurse concerning a 23 year old female patient who in February 2007, was vaccinated IM with a dose of Gardasil (lot# 656049/0187U).  Subsequently the patient was diagnosed with cervical cancer and was hospitalized.  The cold knife cone biopsy was performed on 03-May-2007 and "margins were clear".  The cervix was still intact.  In June 2007 the patient was recovered.  The reporting investigator considered cervical cancer to be disabling.  Upon internal review cervical cancer considered to be an other important medical event.  No product quality complaint was involved.  Additional information has been requested.  4/7/09 Received consultant medical records of 5/23/07-7/28/2008. FINAL DX: adenocarcinoma in situ Records reveal patient dx 3/2006 via LEEP procedure.  Subsequent Pap smear abnormal w/HGSIL, cervical biopsies 2/07.  Cold knife cone procedure in OR on 5/3/07 c/w CIN 2 w/marked changes of HPV infection.  RTC 2/6/08 w/right pelvic pain & fatigue.  Had recent colonoscopy for loose stools which was WNL.  Colposcopy done at that visit was WNL.  Referred to PCP for fatigue.  RTC 7/28/08 w/fatigue, bilateral intermittent ovarian pain & pain w/intercourse.  BCP d/c 7/08. Colposcopy done WNL.  Referred for pelvic US.
Bilateral hives arms, legs, torso. Ongoing 20+min. Does not require clinical treatment.
pt recvd vax on 17JUL91 & recvd 2nd dose of vax 22AUG91 & 3rd dose 23JAN92 & devel psoriasis & joint pains. lab eval revealed Anti-HBs titer was 6.3. 10MAR92 pt recvd 4th dose of vax lab eval on 21APR92 revealed Anti-HBs titer was 15.9;
No adverse effect; multiple patients were vaccinated with improperly stored VARIVAX; This spontaneous report was received from a medical assistant refers to a patient of an unknown age and gender. The patient's pertinent medical history, concurrent condition, concomitant drug and drug reactions/allergies were not reported. On 09-MAY-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose, route was not reported) lot # r024023, expiration date of 22-AUG-2019, one dose for prophylaxis (product storage error). Other suspect therapies included sterile diluent (strength, dose, frequency, route, lot/batch#, expiration date were unknown) for prophylaxis. No adverse effects were reported. There was a previous temperature excursion and the time frame and temperature was unknown. No product quality complaint was involved.
1 1/2" diameter redness no induration or tenderness -  no cellulitis - no treatment necessary
chills; got hard; arm was puffy, swelled up very badly, and it got hard and red.; hurt when needle put in arm still sore; got red; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE INDURATION (got hard), VACCINATION SITE SWELLING (arm was puffy, swelled up very badly, and it got hard and red.), VACCINATION SITE PAIN (hurt when needle put in arm still sore), VACCINATION SITE ERYTHEMA (got red) and CHILLS (chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE INDURATION (got hard), VACCINATION SITE SWELLING (arm was puffy, swelled up very badly, and it got hard and red.), VACCINATION SITE PAIN (hurt when needle put in arm still sore) and VACCINATION SITE ERYTHEMA (got red). On 29-Jan-2021, the patient experienced CHILLS (chills). At the time of the report, VACCINATION SITE INDURATION (got hard), VACCINATION SITE SWELLING (arm was puffy, swelled up very badly, and it got hard and red.), VACCINATION SITE PAIN (hurt when needle put in arm still sore), VACCINATION SITE ERYTHEMA (got red) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Additional information received: Updated event outcome updated
Pt recvd vax on 16SEP92 & 4 hrs following vax exp malaise, fever, sore throat, chills, rash & itching; seen by MD who noted that pt temp was nl & skin was better;
Dec 26 woke up at 0400 with fever 101.6 , chills, sever headache, body aches and very dizzy and nauseated sick for 3 days
sick; flu; Initial information was received on 04-Jan-2021 regarding an unsolicited valid non-serious social media case from a consumer.  This case involves patient (unknown demography) who was sick (illness) and had flu (influenza), while the patient received INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious was sick (illness) (unknown latency) and had flu (influenza) (few weeks) following the administration of INFLUENZA VACCINE.  It was reported that, the flu shot always made the patient sick. The patient stopped taking it 11 years ago when got the flu a few weeks after getting the shot, haven't taken it since and haven't been sick since, will never take it again.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for both the events.  There will be no information available on the batch number for this case.
This  76 year old female received the Pfizer Covid shot on 2/27 /21    and went to the ED on  4/3/21     and was admitted  on 4/3/21 with the following diagnoses listed below. I63.9 - CVA (cerebral vascular accident) I63.9 - Cerebral infarction, unspecified
Expired Bexsero Administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 17-year-old male patient who received Men B NVS (Bexsero) (batch number ABXB58AA, expiry date 30th September 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 4th October 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 4th October 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 26-OCT-2022 Reporter's Comment: The reporter reported that, the maladministration of Bexsero after the expiration date to the patient.  The reporter consented to follow up. Additional Supportive Information: The reporter reported that, the maladministration of Bexsero after the expiration date to the patient, which led to expired vaccine used.
Sore arm since shot 3 weeks ago. Mostly felt when arm raised above head. Pain is in bicep at injection area.